4//SEC Filing
Goldberg Andrew D. 4
Accession 0001819790-25-000030
CIK 0001819790other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:01 PM ET
Size
6.7 KB
Accession
0001819790-25-000030
Insider Transaction Report
Form 4
Goldberg Andrew D.
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2025-03-07−7,000→ 0 totalExercise: $12.89Exp: 2032-06-15→ Common Stock (7,000 underlying) - Exercise/Conversion
Common Stock
2025-03-07$12.89/sh+7,000$90,230→ 13,350 total
Footnotes (1)
- [F1]Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2021 annual meeting of stockholders. The option vested in full on the one-year anniversary of the date of grant.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001827722
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:01 PM ET
- Size
- 6.7 KB